ReviewAnnals of biomedical engineering2026
Plant-Based Scaffolds in Tissue Engineering: Structure-Function, Processing, and Clinical Outlook-A Review.
Review in Annals of biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The escalating demand for functional tissue-engineered constructs has highlighted the critical need for scaffolds that are not only biocompatible but also cost-effective and scalable, qualities that are often lacking in traditional synthetic or animal-derived materials. Driven by this necessity, plant-derived biomaterials have emerged as promising candidates due to their natural abundance and structurally versatile architecture. Primarily composed of cellulose-rich extracellular matrices, hemicellulose, lignin, and pectin, these materials provide physicochemical properties that can be tailored to emulate specific tissue microenvironments. Notably, native plant vasculature contains intrinsic microchannels that facilitate perfusion, making them uniquely advantageous for cell infiltration and angiogenesis. This review aims to synthesize current progress in plant-based scaffolds for tissue engineering, with emphasis on structure-function relationships, processing strategies, and translational readiness. We outline key biofabrication workflows centered on decellularization and preservation of ultrastructure, followed by recellularization approaches and considerations of degradation behavior and mechanical stability. This review also summarizes mechanistic foundations of regeneration, including cell-material interactions, hierarchical microarchitecture, and contributions of intrinsic or incorporated bioactive constituents. Finally, we discuss therapeutic applications across soft and hard tissues and highlight performance enhancement strategies. Importantly, it is worth noting that the current evidence base remains strictly preclinical, with no human clinical trials reported to date. Significant challenges persist, including incomplete decellularization, limited long-term mechanical stability under physiological loading, and the lack of standardized manufacturing protocols. Overall, plant-based scaffolds represent a maturing and sustainable platform with strong potential for future regenerative strategies, contingent upon rigorous standardization and comprehensive safety evaluation.
Indexed as
Identifiers
41870758What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.